UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update

Respiratory medicine, 2009-08, Vol.103 (8), p.1098-1113

2009

Volltextzugriff (PDF)

A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide

Orphanet journal of rare diseases, 2021-01, Vol.16 (1), p.8-8, Article 8

2021

Volltextzugriff (PDF)

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients

Neurology and therapy, 2023-08, Vol.12 (4), p.1081-1101

2023

Volltextzugriff (PDF)

Publisher Correction: Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients

Neurology and therapy, 2023-08, Vol.12 (4), p.1103-1103

2023

Volltextzugriff (PDF)

Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey

Molecular genetics and metabolism reports, 2018-03, Vol.14 (C), p.73-79

2018

Volltextzugriff (PDF)

A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD)

Multiple sclerosis and related disorders, 2023-07, Vol.75, p.104760-104760, Article 104760

2023

Volltextzugriff (PDF)

Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)

American journal of hematology, 2018-02, Vol.93 (2), p.205-212

2018

Volltextzugriff (PDF)

Study to determine predictive potential of an algorithm for earlier diagnosis of Gaucher disease: Retrospective biobank study utilizing real-world data available in Finland

Molecular genetics and metabolism, 2019-02, Vol.126 (2), p.S129-S129

2019

Volltextzugriff (PDF)

Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians

Molecular genetics and metabolism, 2017-11, Vol.122 (3), p.122-129

2017

Volltextzugriff (PDF)

Comparative Economics of On-Demand Treatment Options Approved in the United Kingdom for Hereditary Angioedema

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.AB33-AB33

2013

Volltextzugriff (PDF)

Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey

Blood cells, molecules, & diseases, 2018-02, Vol.68, p.226-231

2018

Volltextzugriff (PDF)

Long-term analysis of velaglucerase alfa-treated patients with Gaucher disease who entered the Gaucher Outcomes Survey (GOS) real-life registry

Molecular genetics and metabolism, 2019-02, Vol.126 (2), p.S91-S91

2019

Volltextzugriff (PDF)

Treatment patterns from 647 patients with Gaucher disease: an analysis from the Gaucher Outcome Survey

Molecular genetics and metabolism, 2017-01, Vol.120 (1-2), p.S40-S41

2017

Volltextzugriff (PDF)

Medical histories in Gaucher disease: a descriptive analysis from 852 patients in the Gaucher Outcome Survey (GOS)

Molecular genetics and metabolism, 2017-01, Vol.120 (1-2), p.S45-S45

2017

Volltextzugriff (PDF)

Patient Satisfaction with 20% Subcutaneous Immunoglobulin (Hizentra®) Treatment: Results From a Single-Center Study in Children with Immunodeficiencies

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.AB155-AB155

2013

Volltextzugriff (PDF)

Characteristics of 27 patients with type 3 Gaucher disease: a descriptive analysis from the Gaucher Outcome Survey

Molecular genetics and metabolism, 2017-01, Vol.120 (1-2), p.S120-S121

2017

Volltextzugriff (PDF)

Reported outcomes of 453 pregnancies in patients with Gaucher disease: an analysis from the Gaucher Outcome Survey

Molecular genetics and metabolism, 2017-01, Vol.120 (1-2), p.S80-S80

2017

Volltextzugriff (PDF)

Data on neuraminidase inhibitors were made available

BMJ (Online), 2004-02, Vol.328 (7438), p.523

Panahloo, Zoya

International edition, 2004

Volltextzugriff (PDF)

Management goals and normalization concept for type 1 Gaucher disease: Results from a survey of expert physicians

Molecular genetics and metabolism, 2018-02, Vol.123 (2), p.S94-S94

2018

Volltextzugriff (PDF)

Experience with Scig Infusion in Patients with Primary Immunodeficiencies: From Clinical Trials to Real-World Practice

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.AB227-AB227

2013

Volltextzugriff (PDF)

Corrigendum to “The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update” [Respiratory Medicine 103 (2009) 1098–1113]

Respiratory medicine, 2010-06, Vol.104 (6), p.924-924

2010

Volltextzugriff (PDF)

Corrigendum to "The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update" [Respiratory Medicine 103 (2009) 1098-1113]

Respiratory medicine, 2010-06, Vol.104 (6), p.924

2010

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Humans
(6)
Allergy And Immunology
(3)
Child
(3)
Enzyme Replacement Therapy
(3)
Female
(3)
Gaucher Disease
(3)
Genetics & Heredity
(3)
Medical Research
(3)
Surveys And Questionnaires
(3)
Adult
(2)
Antibodies
(2)
Asthma
(2)
Care And Treatment
(2)
Clinical Neurology
(2)
Diagnosis
(2)
Gaucher's Disease
(2)
Glucosylceramidase - Therapeutic Use
(2)
Hematology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update

A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients

Publisher Correction: Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients

Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey

A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD)

Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)

Study to determine predictive potential of an algorithm for earlier diagnosis of Gaucher disease: Retrospective biobank study utilizing real-world data available in Finland

Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians

Comparative Economics of On-Demand Treatment Options Approved in the United Kingdom for Hereditary Angioedema

Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey

Long-term analysis of velaglucerase alfa-treated patients with Gaucher disease who entered the Gaucher Outcomes Survey (GOS) real-life registry

Treatment patterns from 647 patients with Gaucher disease: an analysis from the Gaucher Outcome Survey

Medical histories in Gaucher disease: a descriptive analysis from 852 patients in the Gaucher Outcome Survey (GOS)

Patient Satisfaction with 20% Subcutaneous Immunoglobulin (Hizentra®) Treatment: Results From a Single-Center Study in Children with Immunodeficiencies

Characteristics of 27 patients with type 3 Gaucher disease: a descriptive analysis from the Gaucher Outcome Survey

Reported outcomes of 453 pregnancies in patients with Gaucher disease: an analysis from the Gaucher Outcome Survey

Data on neuraminidase inhibitors were made available

Management goals and normalization concept for type 1 Gaucher disease: Results from a survey of expert physicians

Experience with Scig Infusion in Patients with Primary Immunodeficiencies: From Clinical Trials to Real-World Practice

Corrigendum to “The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update” [Respiratory Medicine 103 (2009) 1098–1113]

Corrigendum to "The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update" [Respiratory Medicine 103 (2009) 1098-1113]

Suchergebnisse filtern